JP Morgan Chase’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $28.2M | Sell |
207,100
-68,900
| -25% | -$9.65M | ﹤0.01% | 1793 |
|
|
2025
Q4 | $33.9M | Buy |
276,000
+31,500
| +13% | +$3.83M | ﹤0.01% | 1631 |
|
|
2025
Q3 | $27.1M | Sell |
244,500
-42,000
| -15% | -$4.77M | ﹤0.01% | 1847 |
|
|
2025
Q2 | $31.8M | Buy |
286,500
+247,500
| +635% | +$26.3M | ﹤0.01% | 1621 |
|
|
2025
Q1 | $4.37M | Sell |
39,000
-34,600
| -47% | -$3.57M | ﹤0.01% | 3271 |
|
|
2024
Q4 | $6.8M | Sell |
73,600
-800
| -1% | -$72K | ﹤0.01% | 3065 |
|
|
2024
Q3 | $6.24M | Buy |
74,400
+2,700
| +4% | +$206K | ﹤0.01% | 3052 |
|
|
2024
Q2 | $4.92M | Sell |
71,700
-23,100
| -24% | -$1.54M | ﹤0.01% | 3050 |
|
|
2024
Q1 | $6.94M | Sell |
94,800
-39,400
| -29% | -$3.03M | ﹤0.01% | 2803 |
|
|
2023
Q4 | $10.9M | Sell |
134,200
-50,200
| -27% | -$3.91M | ﹤0.01% | 2389 |
|
|
2023
Q3 | $13.8M | Buy |
184,400
+115,900
| +169% | +$8.91M | ﹤0.01% | 1978 |
|
|
2023
Q2 | $5.28M | Sell |
68,500
-56,200
| -45% | -$4.48M | ﹤0.01% | 2814 |
|
|
2023
Q1 | $10.3M | Sell |
124,700
-29,300
| -19% | -$2.43M | ﹤0.01% | 2254 |
|
|
2022
Q4 | $13.2M | Buy |
154,000
+42,900
| +39% | +$3.4M | ﹤0.01% | 2017 |
|
|
2022
Q3 | $6.85M | Hold |
111,100
| – | – | ﹤0.01% | 2460 |
|
|
2022
Q2 | $6.87M | Sell |
111,100
-151,100
| -58% | -$9.36M | ﹤0.01% | 2487 |
|
|
2022
Q1 | $15.6M | Sell |
262,200
-293,600
| -53% | -$18.8M | ﹤0.01% | 1971 |
|
|
2021
Q4 | $40.4M | Buy |
555,800
+399,900
| +257% | +$27.5M | ﹤0.01% | 1327 |
|
|
2021
Q3 | $10.9M | Sell |
155,900
-224,100
| -59% | -$15.7M | ﹤0.01% | 2311 |
|
|
2021
Q2 | $26.2M | Buy |
380,000
+329,400
| +651% | +$22M | ﹤0.01% | 1608 |
|
|
2021
Q1 | $3.27M | Sell |
50,600
-348,500
| -87% | -$22.5M | ﹤0.01% | 3324 |
|
|
2020
Q4 | $23.3M | Sell |
399,100
-207,700
| -34% | -$12.5M | ﹤0.01% | 1514 |
|
|
2020
Q3 | $37.7M | Buy |
606,800
+431,800
| +247% | +$29.9M | 0.01% | 1121 |
|
|
2020
Q2 | $13.5M | Sell |
175,000
-201,700
| -54% | -$15.5M | ﹤0.01% | 1677 |
|
|
2020
Q1 | $28.2M | Buy |
376,700
+29,300
| +8% | +$2.02M | 0.01% | 1061 |
|
|
2019
Q4 | $22.6M | Buy |
347,400
+259,400
| +295% | +$16.9M | ﹤0.01% | 1495 |
|
|
2019
Q3 | $5.58M | Sell |
88,000
-100,000
| -53% | -$6.54M | ﹤0.01% | 2614 |
|
|
2019
Q2 | $12.6M | Sell |
188,000
-351,300
| -65% | -$23.1M | ﹤0.01% | 1912 |
|
|
2019
Q1 | $35.1M | Buy |
539,300
+321,700
| +148% | +$21.4M | 0.01% | 1164 |
|
|
2018
Q4 | $13.6M | Sell |
217,600
-275,100
| -56% | -$19.2M | ﹤0.01% | 1775 |
|
|
2018
Q3 | $38M | Buy |
492,700
+180,000
| +58% | +$13.6M | 0.01% | 1186 |
|
|
2018
Q2 | $22.2M | Buy |
312,700
+67,000
| +27% | +$4.73M | ﹤0.01% | 1507 |
|
|
2018
Q1 | $18.5M | Sell |
245,700
-211,900
| -46% | -$16.8M | ﹤0.01% | 1563 |
|
|
2017
Q4 | $32.8M | Sell |
457,600
-980,000
| -68% | -$74.4M | 0.01% | 1222 |
|
|
2017
Q3 | $116M | Buy |
1,437,600
+1,192,200
| +486% | +$91.2M | 0.03% | 563 |
|
|
2017
Q2 | $17.4M | Buy |
245,400
+5,400
| +2% | +$359K | ﹤0.01% | 1555 |
|
|
2017
Q1 | $16.3M | Buy |
240,000
+138,700
| +137% | +$9.75M | ﹤0.01% | 1595 |
|
|
2016
Q4 | $7.25M | Sell |
101,300
-63,100
| -38% | -$4.69M | ﹤0.01% | 2154 |
|
|
2016
Q3 | $13M | Buy |
164,400
+78,400
| +91% | +$6.37M | ﹤0.01% | 1620 |
|
|
2016
Q2 | $7.17M | Sell |
86,000
-259,000
| -75% | -$23M | ﹤0.01% | 2057 |
|
|
2016
Q1 | $31.7M | Buy |
345,000
+17,600
| +5% | +$1.59M | 0.01% | 1043 |
|
|
2015
Q4 | $33.1M | Buy |
327,400
+221,500
| +209% | +$23M | 0.01% | 1020 |
|
|
2015
Q3 | $10.4M | Sell |
105,900
-118,144
| -53% | -$13.1M | ﹤0.01% | 1734 |
|
|
2015
Q2 | $26.2M | Sell |
224,044
-347,989
| -61% | -$38M | 0.01% | 1238 |
|
|
2015
Q1 | $56.1M | Buy |
572,033
+72,585
| +15% | +$7.37M | 0.01% | 839 |
|
|
2014
Q4 | $47.1M | Buy |
499,448
+283,447
| +131% | +$29.3M | 0.01% | 957 |
|
|
2014
Q3 | $23M | Buy |
+216,001
| New | +$21.2M | 0.01% | 1358 |
|
|
2014
Q1 | – | Sell |
-37,100
| Closed | -$2.79M | – | 3702 |
|
|
2013
Q4 | $2.79M | Sell |
37,100
-33,900
| -48% | -$2.36M | ﹤0.01% | 2544 |
|
|
2013
Q3 | $4.46M | Sell |
71,000
-12,100
| -15% | -$723K | ﹤0.01% | 2256 |
|
|
2013
Q2 | $4.26M | Buy |
+83,100
| New | +$4.33M | ﹤0.01% | 2245 |
|
Other funds holding GILD
VCM
VPM
JP Morgan Chase's GILD Position: Q1 2026 in Review
JP Morgan Chase increased its Gilead Sciences (GILD) stake by 48% in Q1 2026, buying an estimated $1.53B and bringing the position to 33,992,410 shares worth $4.63B. The position accounts for 0.3% of the portfolio, ranked #69.
JP Morgan Chase first reported a position in GILD in Q2 2013 and has held it in 52 quarters since. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.
- JP Morgan Chase held 33,992,410 shares of Gilead Sciences worth $4.63B as of Q1 2026.
- JP Morgan Chase bought 10,956,647 Gilead Sciences shares in Q1 2026, an estimated $1.53B.
- Gilead Sciences made up 0.3% of JP Morgan Chase's portfolio in Q1 2026, its #69 holding.
- JP Morgan Chase first reported a position in Gilead Sciences in Q2 2013 and has held it in 52 quarters since.
- 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.
Based on JP Morgan Chase's 13F filing for Q1 2026, filed 13 May 2026.